Showing results (461-470 of 744) with videos related to

Sort By:
Pageof 75
Medical Oncology (Northwood, London, England)|July 19, 2025
Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomasEmadeldin M Kamel, Sally Mostafa Khadrawy, Ahmed A Allam, et al.
Thrombosis Research|September 10, 2025
CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies and antithrombotic opportunitiesEmadeldin M Kamel, Sulaiman A Alsalamah, Ahmed A Allam, et al.
Bioorganic Chemistry|July 4, 2024
Deciphering molecular mechanisms underlying the inhibition of β-glucuronidase by xanthones from Centaurium spicatumEmadeldin M Kamel, Haifa A Alqhtani, May Bin-Jumah, et al.
Biochemical and Biophysical Research Communications|September 13, 2024
Unraveling the mechanism of carbonic anhydrase IX inhibition by alkaloids from Ruta chalepensis: A synergistic analysis of in vitro and in silico dataHaifa A Alqhtani, Sarah I Othman, Faris F Aba Alkhayl, et al.
Future Medicinal Chemistry|October 28, 2017
Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effectMohamed A Abdelgawad, Rania B Bakr, Ahmed O El-Gendy, et al.
Research in Social & Administrative Pharmacy : RSAP|July 21, 2022
Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative studyAsmaa S Mohamed, Hosam M Ahmad, Alyaa S A Abdul-Raheem, et al.
Psoriasis (Auckland, N.Z.)|July 2, 2020
Circulating Cell -Free DNA as Inflammatory Marker in Egyptian Psoriasis PatientsHaneya A A Anani, Amany M Tawfeik, Soheir S Maklad, et al.
RSC Advances|June 10, 2025
Disrupting the Hsp90-Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancerEmadeldin M Kamel, Mohamed A M Ali, Ahmed A Allam, et al.
Pageof 75